JORGE RIVERA-COLON: Open Payments
NPI 1396951414 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 19 payments from 6 companies in 2025. Trend: 2023 $193 · 2024 $96 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $144 |
| Janssen Pharmaceuticals, Inc | 3 | $109 |
| ABBVIE INC. | 5 | $93 |
| Alkermes, Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: INVEGA SUSTENNA, VRAYLAR, REXULTI, ABILIFY ASIMTUFII, ARISTADA, UZEDY, TRINTELLIX, LYBALVI.
Industry payments across PA — which companies pay providers there.
